Long-term isoagglutinin monitoring after ABO-incompatible kidney transplantation.
Han Joo KimYousun ChungHyungsuk KimYoungmin KoYoung Hoon KimSang-Hyun HwangHeung-Bum OhDae-Hyun KoPublished in: American journal of clinical pathology (2024)
Our findings suggest that a 2-week monitoring period for isoagglutinin titers after ABOi-KT may not be sufficient to detect late AMR. Extending the monitoring duration and considering lifelong fresh-frozen plasma transfusion with graft-compatible blood types, along with periodic isoagglutinin titer testing in cases of suspected AMR, may improve long-term graft outcomes.